In trading on Monday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) entered into oversold territory, hitting an RSI reading of 26.7, after changing hands as low as $21.89 per share.

Apellis Pharmaceuticals APLS announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the label expansion of Empaveli (pegcetacoplan) for two rare and severe kidney ...

In this article, we are going to take a look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little easier ...

In this article, we are going to take a look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little easier after ...

The Fairhope Public Library’s state funding likely will not be reinstated anytime soon after the chairman of the state’s library board claimed the board is failing to relocate materials deemed ...

With the volatility of the markets after President Donald Trump’s tariffs and the subsequent 90-day pause, investors may be looking for some guidance in their choices. Luckily, investing legend ...

The revised investment and turnover criteria for micro, small and medium enterprises (MSMEs), effective from April 1, is expected to offer greater opportunities for growth and expansion ...

Apellis Pharmaceuticals Price Performance Shares of APLS opened at $18.20 on Friday. The firm has a market capitalization of $2.28 billion, a price-to-earnings ratio of -8.97 and a beta of 0.85 ...

The APLS board voted in March to temporarily suspend approximately $42,000 in annual state funding the Fairhope Library receives each year from the state, for what were violations to the state’s ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apellis Pharmaceuticals (APLS – Research Report), Skye Bioscience (SKYE – Research Report) and Sarepta ...